Current Edition
Title story
Cancer research
Bayer’s successful acquisition of Schering gave a tremendous boost to Bayer HealthCare’s research capabilities in the battle against cancer. The title story features reports on promising substances that are currently undergoing clinical testing, and takes a look at the new approaches being taken by the Bayer Schering Pharma Division. » more
 |
Nanoparticles Tiny Trojan horses Researchers from Bayer HealthCare are now packaging active ingredients in nanoparticles. » more |
 |
Alzheimer’s Visualizing memory loss Up to now, however, it has only been possible to definitely confirm the presence of the disease after death. » more |
 |
Wound Healing Skin repair kit If an external injury fails to get better within a few weeks, it becomes what is known as a chronic wound. » more |